(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $275.88 | $364.93 | $196.39 | $227.99 |
Inventory | ||||
Total current assets | $1639.54 | $1238.74 | $1398.29 | $1577.7 |
Long term investments | ||||
Property, plant & equipment | $172 | $142.41 | $135.72 | $144.25 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $42275.96 | $42018.89 | $42120.93 | $35311.79 |
Current liabilities | ||||
Accounts payable | $180.05 | $201.54 | $1389.37 | $165.14 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $17865.54 | $17963.63 | $21423.53 | $13888.88 |
Long term debt | $14249.02 | $14729.02 | $11250.79 | $11398.19 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $34619.42 | $34692.3 | $34971.38 | $28304.84 |
Shareholders' equity | ||||
Retained earnings | -$177.66 | -$143.19 | -$232.12 | -$373.14 |
Other shareholder equity | $57.98 | $44.76 | $44.5 | $43.67 |
Total shareholder equity |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $227.99 | $640 | $546 | $385 |
Inventory | ||||
Total current assets | $1577.7 | $2038 | $1994 | $1330 |
Long term investments | ||||
Property, plant & equipment | $144.25 | $115 | $174 | $27 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $35311.79 | $32479 | $39742 | $33252 |
Current liabilities | ||||
Accounts payable | $165.14 | $887 | $317 | $97 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $13888.88 | $12582 | $21558 | $18049 |
Long term debt | $11398.19 | $10644 | $9188 | $8186 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $28304.84 | $25536 | $33138 | $27931 |
Shareholders' equity | ||||
Retained earnings | -$373.14 | -$419 | -$813 | -$1109 |
Other shareholder equity | $43.67 | $38 | $90 | $66 |
Total shareholder equity |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $664.47 | $1321.66 | $1326.66 | $383.54 |
Cost of revenue | ||||
Gross Profit | $154.3 | $855.72 | $916.83 | -$16.93 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $473.72 | $477.57 | $432.97 | $414.07 |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | -$78.43 | $51.65 | $93.41 | $29.85 |
Interest expense | ||||
Net income | ||||
Net income | $97.02 | $213.16 | $261.64 | -$87.53 |
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $3652.57 | $6361 | ||
Cost of revenue | ||||
Gross Profit | $2231.32 | $5523.8 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $1517.84 | $2121.8 | ||
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $122.16 | $279.5 | ||
Interest expense | ||||
Net income | ||||
Net income | $532.68 | $864.8 | ||
Income (for common shares) |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$2087.53 | -$1411.31 | -$4053.22 | $252.52 |
Financing activities | ||||
Dividends paid | -$432.12 | -$286.6 | -$143.3 | -$570.88 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | $2825.69 | $2475.86 | $5055.58 | -$1298.89 |
Effect of exchange rate | ||||
Change in cash and equivalents | $306.32 | -$135.38 | -$141.84 | $55.19 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | $252.52 | $198.3 | $2306.3 | $8645.4 |
Financing activities | ||||
Dividends paid | -$570.88 | -$558.3 | -$438.5 | -$383.6 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$1298.89 | -$6983.1 | -$4742.2 | -$10111.8 |
Effect of exchange rate | ||||
Change in cash and equivalents | $55.19 | $89.3 | $448 | $389.5 |
Market cap | $5.43B |
---|---|
Enterprise value | N/A |
Shares outstanding | 519.73M |
Revenue | $3.70B |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | $484.30M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | 11.21 |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | 1.47 |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | $0.93 |
---|---|
ROA | 1.20% |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 0.09 |
Quick ratio | N/A |